Kyle Gavulic

Kyle A. Gavulic joined the Department of Health Policy in 2020. His primary research interest concerns the role of policies on health outcomes and access to care for underserved populations. Focus areas include (1) comparative health policy (2) high-cost pharmaceutical drugs (3) health disparities, and (4) the non-medical determinants of health. His research in LGBTQ health disparities and US prescription drug pricing has led to publications in the American Journal of Public Health and JAMA Health Forum. Currently his work focuses on the impacts of the COVID-19 pandemic on sexual and gender minority health in addition to examining Medicaid spending of products approved through the Food and Drug Administration’s accelerated approval pathway. Kyle also serves as Editorial Intern of JAMA Health Forum. Kyle holds a Bachelor of Arts in French and Medicine, Health, and Society with a concentration in health economies and policies from Vanderbilt University.